SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-20-008209
Filing Date
2020-07-30
Accepted
2020-07-30 20:28:11
Documents
5

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT gtbp_424b3.htm 424B3 1666233
2 IMAGE gtbp_424b3000.jpg GRAPHIC 3362
3 IMAGE gtbp_424b3001.jpg GRAPHIC 29330
4 IMAGE gtbp_424b3002.jpg GRAPHIC 6197
5 IMAGE gtbp_424b3015.jpg GRAPHIC 4986
  Complete submission text file 0001654954-20-008209.txt   1728538
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-239858 | Film No.: 201063055
SIC: 2834 Pharmaceutical Preparations